Report of Foreign Issuer (6-k)
May 20 2020 - 5:03PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
May 20, 2020
001-36686
(Commission file number)
Forward Pharma A/S
(Translation of registrant’s name
into English)
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
(Address of principal executive office)
________________________________________
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes [ ] No [ X ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes [ ] No [ X ]
Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934. Yes [ ] No [ X ]
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): N/A
Item 1. Other Items
On May 20, 2020, Forward Pharma A/S (the “Company”)
filed with the Danish Business Authority and made available on its website Amended and Restated Articles of Association, dated
May 7, 2020. The Amended and Restated Articles of Association reflect changes due to the exercise of warrants.
The Company has filed as an exhibit to this
Form 6-K the Amended and Restated Articles of Association, dated May 7, 2020.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 20, 2020
|
Forward Pharma A/S
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Claus Bo Svendsen
|
|
|
|
Name: Claus Bo Svendsen
|
|
|
|
Title: Chief Executive Officer
|
|
EXHIBIT INDEX
99.1 Amended and Restated Articles of Association, dated May 7, 2020.
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Sep 2023 to Sep 2024